{"filings":[{"id":748517,"accession_number":"0001628280-26-039234","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2026-05-29T20:56:01+00:00","items":["5.07"],"status":"ready","headline":"Octave Specialty Group annual meeting results: all proposals pass, directors elected","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Seven directors elected with majority support; ~7.5M broker non-votes per nominee.","Advisory vote on executive compensation passed (19.2M for, 8.2M against).","Ernst & Young ratified as independent auditor for FY2026 (34.2M for).","2026 Incentive Compensation Plan approved (17.3M for, 10.1M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99323,"accession_number":"0001628280-26-031377","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Octave Specialty Q1: Insurance Distribution revenue soars 92%; net loss narrows to $6.9M on Everspan litigation charge","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total P&C premium production up 66% to $531M; Insurance Distribution revenue grew 92% to $79M, with organic growth of 42%.","Adjusted net income to shareholders of $16.6M ($0.37/diluted share) vs net loss of $6.0M in Q1 2025.","Insurance Distribution segment net income of $13M vs loss of $3M; Adjusted EBITDA $25M vs $7M.","Specialty P&C (Everspan) gross written premiums up 19% to $104M, but net loss of $8M due to $7.9M loss/LAE from litigation settlement.","Corporate segment net loss narrowed to $12M from $14M; weighted-average diluted shares 45.3M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":104170000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99322,"accession_number":"0001628280-26-024072","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2026-04-07T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Octave Specialty Group adds $40M term loan to fund minority shareholder put rights","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Additional term loan of $40M under First Amendment to Credit Agreement.","Total outstanding term loans now $139.375M as of April 1, 2026.","Proceeds used to fund Cirrata UK's obligation to honor put rights exercised by minority shareholders of Octave Specialty Limited.","Company pledged ownership interests in Everspan Holdings, LLC as collateral."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115252,"accession_number":"0001628280-26-010639","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2026-02-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Octave Specialty Q4 2025: Net loss from continuing ops $29.98M, adjusted EBITDA improves to $1.35M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $66.9M (+3% YoY); net loss from continuing ops to shareholders $29.98M (diluted EPS -$0.84) vs loss $22.16M (EPS -$0.56) last Q4.","Insurance Distribution: premium production $303M (+15%), commission income $37M (+13%), organic growth 8.1%, segment adjusted EBITDA $7M (+33%).","Everspan: gross premiums written $80M (+34%), net premiums written $23M (+978%), combined ratio below 100%, net income fell 37% to $1M.","Adjusted EBITDA to shareholders $1.35M vs $0.52M; driven by ID segment improvement and corporate cost reductions.","Acquired ArmadaCare and launched 1889 Specialty MGA in Q4; expects strong organic growth in 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-5.93,"consensus_revenue_estimate":null,"consensus_revenue_actual":251222000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115251,"accession_number":"0001628280-26-000870","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2026-01-06T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Octave files ArmadaCorp financials: nine-month revenue $33.4M, net income $16.2M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ArmadaCorp nine-month 2025 revenue $33.4M (up from $32.0M YoY); net income $16.2M vs $15.7M.","Total assets $34.7M; member's equity $8.6M as of Sep 30, 2025.","95.1% of revenue from two carriers: Transamerica (54.7%) and SiriusPoint America (40.4%).","Acquisition closed Oct 31, 2025 for $250M cash, funded partly by $120M borrowings.","Audited financials for years ended Dec 31, 2024 and 2023 also filed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131673,"accession_number":"0001628280-25-057024","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-12-15T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Octave Specialty replaces KPMG with EY as independent auditor for FY2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KPMG dismissed as auditor after serving since 1985; no disagreements or reportable events.","Ernst & Young appointed for fiscal year ending Dec 31, 2026, subject to client acceptance.","KPMG will remain auditor for the year ending Dec 31, 2025 and complete its audit.","Audit Committee conducted competitive RFP; change reflects routine rotation, not conflict."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131672,"accession_number":"0001628280-25-051169","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Ambac rebrands to Octave Specialty Group, new ticker OSG starting Nov 20","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name changed to Octave Specialty Group, Inc. effective Nov 10, 2025; AMBC ticker to OSG on Nov 20.","Subsidiaries rebranded: Cirrata Group becomes Octave Partners, Beat Capital Partners becomes Octave Ventures.","Legacy financial guarantee business sold; company now focused on building MGA platform across U.S., U.K., Bermuda.","CEO Claude LeBlanc says rebrand marks culmination of transformation into a diversified specialty insurance enterprise."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131671,"accession_number":"0001628280-25-051048","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ambac Q3 net loss $112.6M; Insurance Distribution revenue up 80%, Everspan premiums down","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss attributable to shareholders of $112.6M ($2.35 per diluted share) vs $27.5M loss last year.","Total P&C premium production up 32% to $343M; Insurance Distribution revenue grew 80% to $43M.","Adjusted EBITDA from continuing ops to shareholders was -$2.9M vs +$1.9M YoY.","Everspan net premiums written down 46% to $18M; expects combined ratio improvements by 2026-27.","AFG repurchased 3.1M shares in Oct. at avg $8.48 (6.7% of shares outstanding)."],"consensus_eps_estimate":null,"consensus_eps_actual":-5.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":184319000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131670,"accession_number":"0001628280-25-047943","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["1.01","2.01","2.02","7.01","9.01"],"status":"ready","headline":"Ambac completes $250M acquisition of ArmadaCare from SiriusPoint; debt financing in place","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration ~$250M; funded via $100M term loan, $20M revolver draw, and cash on hand.","Credit agreement with Truist Bank provides $120M senior secured facilities; borrowings bear SOFR plus 2.25%-2.75% margin.","ArmadaCare to retain brand, led by CEO Ed Walker, operate as wholly owned subsidiary of Ambac.","Ambac CEO Claude LeBlanc cites strengthened financial profile, diversified distribution platform."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148239,"accession_number":"0001628280-25-043221","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-09-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Ambac accelerates PSU vesting for CEO, CFO, COO after Assurance sale; 2023 awards at 121.5%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["PSU acceleration effective Sept 30, 2025, after Sept 29 closing of Ambac Assurance sale.","2023 PSUs vest at 121.5% of target; 2024 PSUs at 100% of target.","CEO Claude LeBlanc receives 368,313 vested PSUs, CFO David Trick 89,071, COO R. Sharon Smith 79,441.","Committee cited concluded legacy business activities as reason for acceleration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148238,"accession_number":"0001628280-25-043138","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ambac Financial Group enters new employment agreements with CEO, CFO, and COO including special cash and equity awards","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Claude LeBlanc receives $900,000 base salary, $2.1M RSU, and performance stock options for 500,000 shares with price hurdles from $18 to $30.","CFO David Trick receives $600,000 base salary, $600,000 RSU, and performance stock options for 350,375 shares with same price hurdles.","COO R. Sharon Smith receives $500,000 base salary, $500,000 RSU, and performance stock options for 284,125 shares with same price hurdles.","Agreements include one-year renewable terms, severance multiples up to 2.5x salary plus bonus, and 12-month non-compete clauses.","Special cash awards of $900k, $600k, and $500k subject to forfeiture if terminated for cause within 12 months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148237,"accession_number":"0001628280-25-043137","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Ambac to acquire ArmadaCare from SiriusPoint for $250M, expects Q4 2025 close","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $250M; financed with $100M term loan and $20M revolver from Truist.","Transaction expected to close Q4 2025, subject to customary regulatory approvals.","Deal expected to be accretive to Ambac shareholders in 2026.","ArmadaCare CEO Ed Walker to continue leading the business; new 5-year capacity agreement with SiriusPoint.","Investor call on Sept 30 at 8:30am ET to discuss strategic update."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148236,"accession_number":"0001628280-25-043087","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["1.01","2.01","3.02","7.01","9.01"],"status":"ready","headline":"Ambac completes $420M sale of legacy financial guarantee businesses to Oaktree","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale of Ambac Assurance Corp and Ambac Assurance UK to Oaktree for $420M cash closed on September 29, 2025.","Completion transforms Ambac into pure-play MGA and specialty insurance platform; CEO calls it defining moment.","Issued Oaktree a warrant for 5,092,707 common shares with conversion options capped at $70M aggregate.","Moelis & Company and Debevoise & Plimpton advised Ambac; BlackRock and Kirkland & Ellis advised Oaktree."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148235,"accession_number":"0000874501-25-000131","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ambac Q2 total revenue up 8% to $55M; net loss widens to $72.7M as legacy sale nears approval","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total P&C premium production surged 110% to $346M, boosted by Beat acquisition.","Cirrata revenue up 148% to $33M; adjusted EBITDA to shareholders rose 28% to $3M.","Everspan combined ratio improved to 107% (down 270 bps) on lower loss ratio of 67.8%.","Net loss from continuing ops to Ambac shareholders $(20.5M) vs $(14.9M) a year ago; adjusted EPS $(0.22).","Wisconsin OCI recommends approval for AAC sale; hearing set Sept 3, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":117713000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148234,"accession_number":"0001193125-25-155881","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-07-07T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"Ambac extends AAC sale to Oaktree to Dec 31, 2025; warrant conversion terms amended","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale of Ambac Assurance (AAC) and Ambac UK to Oaktree extended to Dec 31, 2025; deal price remains $420M cash.","Warrant conversion amended: Oaktree may convert up to one-third of the warrant at a time, aggregate cap $70M.","Oaktree waives right to designate a board director under the Investor Rights Agreement.","Parties to cooperate on office leases and Oaktree waives certain pre-closing company payment adjustments.","Closing still subject to Wisconsin OCI regulatory approval; both parties state full commitment to completion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167008,"accession_number":"0000874501-25-000100","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Ambac Financial extends credit facility maturity to Dec 31, 2025 with $10M repayment Oct 31","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Maturity extended from July 31, 2025 to earlier of Dec 31, 2025 or 3 months after termination of American Acorn SPA.","Requires $10M principal repayment on Oct 31, 2025 plus any mandatory prepayment.","Duration fee of 1.00% of outstanding loans due Nov 3, 2025; extension fee of 1.00% paid.","Must maintain unrestricted cash/cash equivalents >= $30M at all times."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167007,"accession_number":"0000874501-25-000095","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-05-30T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ambac shareholders elect 7 directors, approve say-on-pay, and ratify KPMG","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["78% of shares (36.2M of 46.4M outstanding) represented at May 28 annual meeting.","All 7 director nominees elected: Haft, Iglesias, Lamm-Tennant, LeBlanc, Matus, Price, Stein.","Advisory vote on executive compensation approved: 23.1M for, 6.2M against, 0.8M abstain.","Ratification of KPMG as auditor for FY2025: 35.4M for, 0.5M against, 0.3M abstain.","Advisory frequency vote chose 'Every Year' with 25.8M for, vs ~3.9M for other options."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167006,"accession_number":"0000874501-25-000084","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ambac Q1 revenue up 27% to $63M but net loss widens; adjusted EBITDA negative","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total P&C premium production up 70% to $318M; revenue from continuing ops $63M (+27% YoY).","Net loss from continuing ops attributable to shareholders of $16.1M vs $4.1M loss in Q1'24.","Diluted EPS from continuing ops loss of $1.22 vs prior year EPS of $0.44 gain.","Adjusted EBITDA to shareholders negative $1.3M vs positive $0.4M; Cirrata segment adjusted EBITDA up 136%.","Legacy business sale pending only Wisconsin regulatory approval; discontinued ops net loss of $30.2M."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":62756000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184384,"accession_number":"0000874501-25-000015","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2025-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ambac Q4 net loss $548M on $570M legacy sale charge; P&C premiums up 88%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Continuing ops net loss $22M ($0.70 diluted); adjusted EBITDA $5.1M vs -$3.5M prior year.","Legacy sale to Oaktree for $420M expected to close Q1/Q2 2025 pending Wisconsin approval; $570M disposal loss.","Specialty P&C insurance production rose 88% to $265M; combined ratio improved to 96.5%.","Insurance Distribution revenue up 257% to $44M; Cirrata adj. EBITDA to Ambac shareholders $5.3M.","Stock buybacks: 962K shares at $12.48 in Q4, plus 240K in Q1 2025; $35M authority remaining."],"consensus_eps_estimate":null,"consensus_eps_actual":-10.71,"consensus_revenue_estimate":null,"consensus_revenue_actual":235815000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200980,"accession_number":"0000874501-24-000244","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ambac reports Q3 net loss of $28M ($0.63/diluted); board approves $50M buyback acceleration","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $28M ($0.63 diluted share); adjusted net loss of $19M ($0.46).","Total P&C premium production $260M, up 86% YoY; Everspan combined ratio improved to 100.5%.","Insurance Distribution revenue $24M (+64%); Specialty P&C revenue $40M (+158%).","Beat Capital acquisition closed; three new MGAs added, total now 19.","Legacy Financial Guarantee sale: only Wisconsin OCI approval remains; board accelerated $50M buyback."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":321000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200979,"accession_number":"0000874501-24-000238","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-10-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ambac shareholders approve sale of Ambac Assurance Corp to Oaktree Capital","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale of all Ambac Assurance Corp shares to Oaktree-backed buyer approved with ~36.1M for, 1.9M against.","Advisory vote on executive compensation tied to sale passed with ~34.0M for, 3.8M against.","Adjournment proposal also passed with ~34.6M for; over 38M shares voted (~80% of outstanding).","Purchase agreement dated June 4, 2024; sale may constitute transfer of substantially all company assets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216996,"accession_number":"0000874501-24-000211","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-09-17T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Beat Capital H1 2024 results: turnover up, profit down; pro forma financials filed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Beat Capital H1 2024 turnover £26.4M, up 5.6% from £25.0M in H1 2023.","Beat H1 2024 operating profit £5.7M vs £8.7M in H1 2023; profit after tax £3.97M vs £5.44M.","Beat net assets at June 30, 2024: £21.4M, up from £21.1M at Dec 2023.","Ambac filed pro forma financials combining Beat acquisition and Ambac Assurance sale."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216995,"accession_number":"0000874501-24-000208","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-09-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ambac files 8-K for KBW conference presentation; no specific financial data disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Management presented at KBW Insurance Conference on Sept 4-5, 2024; slides posted on IR website.","Filing includes Rule 14a-12 solicitation notice, but no material update or numbers provided.","Exhibit 99.1 is a cover page only; no new financial guidance or operational metrics in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216994,"accession_number":"0000874501-24-000178","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ambac holds Q2 2024 earnings call on Aug 6; no financial figures in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Furnished transcript of August 6, 2024 earnings call as Exhibit 99.1 under Item 7.01.","No specific revenue, EPS, or segment results are provided in the 8-K or extracted exhibit excerpt.","Investors must review the full transcript for detailed Q2 2024 performance data.","Transcript also filed under Rule 14a-12, indicating possible proxy solicitation context."],"consensus_eps_estimate":null,"consensus_eps_actual":0.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":207000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216993,"accession_number":"0000874501-24-000174","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ambac posts Q2 2024 investor presentation; quarterly highlights included","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Presentation posted on IR website and furnished as Exhibit 99.1 on August 5, 2024.","Filed under Rule 14a-12, indicating it is part of proxy solicitation material.","Specific financial figures or deal updates are not provided in the filing text.","Full presentation is available on Ambac's investor relations page."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216992,"accession_number":"0000874501-24-000171","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ambac reports Q2 adjusted EPS $0.18; closes $278M Beat Capital acquisition, agrees to sell legacy business for $420M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss under $1M ($0.02 diluted); adjusted net income $8M ($0.18 diluted) for Q2 2024.","Closed acquisition of 60% stake in Beat Capital Partners for $278M, effective July 31, 2024.","Agreed to sell Legacy Financial Guarantee Business to Oaktree for $420M, pending regulatory and shareholder approvals.","Everspan GPW $111M (+109% YoY); total P&C premium production $165M (+75%) driven by new programs.","To initiate $50M share repurchase program after sale of Legacy Financial Guarantee Business."],"consensus_eps_estimate":null,"consensus_eps_actual":0.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":207000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216991,"accession_number":"0000874501-24-000166","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-08-02T23:59:59+00:00","items":["1.01","2.01","2.03","3.02","7.01","9.01"],"status":"ready","headline":"Ambac completes $278M acquisition of 60% stake in Beat Capital Partners; P&C platform doubles","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration of ~$277.9M: $248.6M cash plus 2,216,023 shares of AMBC common stock.","Deal doubles P&C operation; expected to produce ~$1.4B annualized premiums for 2024.","Beat's London-based MGA incubation platform adds 16 MGAs to Cirrata Group; existing management continues under Chairman John Cavanagh.","Financed via $150M term loan facility (matures July 31, 2025) with SOFR+4.5% margin, stepping up to 7.5% by May 2025.","Rollover shareholders (Bain Capital and management) receive put/call options starting March 2026 for up to 25% of shares annually."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216990,"accession_number":"0000874501-24-000164","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-08-02T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Ambac closes acquisition of 60% of Beat Capital for $277.9M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration ~$277.9M: $248.6M cash plus 2,216,023 shares of AMBC common stock.","Beat's FY2023 continuing ops turnover £46.2M, profit before tax £14.5M (UK GAAP).","Beat net assets at Dec 31, 2023: £21.1M; paid £8M dividends in FY2023.","Beat launched two new businesses in 2024: credit insurance and accident & health insurance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236747,"accession_number":"0000874501-24-000144","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-06-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ambac files 8-K with investor presentation at BMO conference; no material financial data disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation delivered at BMO Capital Markets Insurance Conference on June 13, 2024, and posted on Ambac's website.","Filing includes check box indicating soliciting material under Rule 14a-12, suggesting proxy-related content.","Exhibit 99.1 excerpt contains only disclaimers and cover page; substantive presentation content not included in filing extract.","No quarterly results, guidance, or strategic announcements were provided in the 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236746,"accession_number":"0000874501-24-000141","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-06-07T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ambac shareholders elect seven directors, approve incentive plan and charter amendments at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected all seven board nominees (Haft, Iglesias, Lamm-Tennant, LeBlanc, Matus, Price, Stein) with majority support.","Approved advisory say-on-pay: 30.6M for, 1.7M against (94.9% for of votes cast).","Ratified KPMG as independent auditor for FY2024: 37.0M for, 0.6M against (97.6% for).","Approved 2024 Incentive Compensation Plan: 21.2M for, 11.0M against (65.8% for of votes cast).","Approved three charter amendments, including extending exculpation to officers and removing bankruptcy code references."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236745,"accession_number":"0000874501-24-000139","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-06-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Ambac holds strategic update call on two pending M&A transactions; no deal terms disclosed","summary_kind":"llm","event_type":"m_and_a","confidence":"low","bullets":["Call on June 5, 2024 discussed AAC Transaction and Beat Transaction; proxy statement to be filed.","Participants included CEO Claude LeBlanc, CFO David Trick, and Beat Capital Chairman John Cavanagh.","No deal value, premium, or expected close date mentioned in the furnished transcript excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236744,"accession_number":"0000874501-24-000131","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-06-05T23:59:59+00:00","items":["1.01","2.03","3.02","7.01","9.01"],"status":"ready","headline":"Ambac to sell AAC to Oaktree for $420M cash; acquire 60% of Beat Capital for ~£222M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sells Ambac Assurance (AAC) to Oaktree for $420M cash; Oaktree gets warrant for 9.9% of AMBC shares at $18.50.","Acquires ~60% of Beat Capital Partners for £221.6M plus £22.5K/day from Dec 31, 2023 to close; up to $40M paid in stock.","Beat management and Bain Capital each retain ~20% post-closing; Ambac enters shareholder agreement with put/call options from 2026.","Beat purchase funded via available cash, AAC proceeds (repaid at AAC close), and a $150M senior secured bridge loan from UBS.","AAC sale requires shareholder vote; both deals subject to regulatory approvals with end date of April 4, 2025 for AAC sale."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236742,"accession_number":"0000874501-24-000137","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K/A","filed_at":"2024-06-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Ambac agrees to sell Ambac Assurance to American Acorn for $420M; shareholder vote required","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price of $420M plus adjustment amount for 100% of Ambac Assurance Corporation shares.","Buyer American Acorn Corp. also gets a warrant for 9.9% of fully diluted Ambac common stock.","Transaction requires stockholder approval under DGCL Section 271; board unanimously recommends.","Closing subject to regulatory approvals, other conditions; sponsor equity commitment letter in place.","Transition services and employment agreements with key employees effective at closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236743,"accession_number":"0000874501-24-000127","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ambac Q1 net income $20M, adjusted EPS $0.82; P&C premium production up 45% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $20M ($0.43/diluted share); adjusted net income $38M ($0.82/share).","Specialty P&C combined ratio 98.4%, improving from 121.9% YoY; first quarterly underwriting profit.","P&C premium production $187M, up 45% YoY; Cirrata EBITDA $5M on $90M premiums placed.","Legacy Financial Guarantee pretax income $24.8M vs loss $32.1M; strategic review ongoing with active discussions.","Book value per share $30.19; adjusted book value $29.03, up marginally from prior quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":0.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":103000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254369,"accession_number":"0000874501-24-000039","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ambac Q4 net loss $16M, adjusted income $10M; P&C premiums up 76%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net loss attributable to common stockholders $15.7M ($0.24 diluted EPS); adjusted net income $10.2M ($0.32 diluted EPS).","Specialty P&C segment (Everspan) gross written premium $90.7M, up 76% YoY; combined ratio improved to 100.3%.","Insurance Distribution (Cirrata) premiums placed $50.2M, up 31% YoY; pretax income $0.6M.","Legacy Financial Guarantee segment net loss $12.2M from lower premiums and $19M defensive litigation in prior year."],"consensus_eps_estimate":null,"consensus_eps_actual":0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":269000000.0,"consensus_period":"2023-12-31","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254368,"accession_number":"0000874501-24-000038","cik":874501,"company_name":"OCTAVE SPECIALTY GROUP INC","ticker":"OSG","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Ambac enters new regulatory stipulation with Wisconsin OCI, replacing 2018 order","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["New Stipulation and Order effective Feb 22, 2024, supersedes 2018 order (Case 17-C42069).","OCI requires AAC to maintain surplus and contingency reserves at a level avoiding financial hazard; use a capital model per OCI specifications.","Removed prior affirmative covenants on books/records and certain reporting; affiliate transaction threshold relaxed to lower of $25M or applicable limit.","Non-ordinary course transactions ≥$100M by AAC require OCI non-disapproval; changes to Investment Policy or Derivative Use Plan need OCI approval.","AFGI must use best efforts to preserve NOLs for AAC's benefit; OCI may terminate/modify order consistent with policyholder interests."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":242173142.7509025,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}